Amgen Q2 26 Earnings
Revenue: $10.05B (est $9.44B) Adjusted EPS: $6.29 (est $5.62) Adjusted Operating Income: $4.61B (est $4.18B) Sees FY Revenue: $38.2B To $39.4B, Saw $37.1B To $38.5B Sees FY Adjusted EPS: $22.30 To $23.50, Saw $21.70 To $23.10 Lifts FY Outlook After Blockbuster Sales Top Expectations
Story updates
08:13:42 PM UTC
SquawkNews
Amgen Q2 26 Earnings
Revenue: $10.05B (est $9.44B) Adjusted EPS: $6.29 (est $5.62) Adjusted Operating Income: $4.61B (est $4.18B) Sees FY Revenue: $38.2B To $39.4B, Saw $37.1B To $38.5B Sees FY Adjusted EPS: $22.30 To $23.50, Saw $21.70 To $23.10 Lifts FY Outlook After Blockbuster Sales Top Expectations